Shigeharu Tsurumi

Low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (CAG regimen) for previously treated patients with relapsed or primary resistant acute myelogenous leukemia (AML) and previously untreated elderly patients with AML, secondary AML, and refractory anemia with excess blasts in transformation.

Kenji Saito, Y Nakamura, Mitsuo Aoyagi et al. · PubMed · 2000 · 72 citations

Medicine, Hematology, Pharmacology +17

Prednisone versus high-dose dexamethasone for untreated primary immune thrombocytopenia. A retrospective study of the Japan Hematology & Oncology Clinical Study Group

Kana Sakamoto, Hideki Nakasone, Shigeharu Tsurumi et al. · Journal of Thrombosis and Thrombolysis · 2013 · 29 citations · Full text

Medicine, Hematology, Oncology +11

N‐ras and p53 gene mutations in Japanese patients with myeloproliferative disorders

Shigeharu Tsurumi, Yuichi Nakamura, Kazuhiro Maki et al. · American Journal of Hematology · 2002 · 17 citations · Full text

Medicine, Genetics, Hematology +16